Trial Profile
Efficacy and serum levels of infliximab in patients with rheumatoid arthritis: A retrospective observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 01 Aug 2016 New trial record
- 05 Jul 2016 According to Celltrion media release, Professor Chamaida Plasencia of La Paz University Hospital-Idipaz in Madrid, Spain is the investigator of this study.
- 11 Jun 2016 Results presented at the 17th Annual Congress of the European League Against Rheumatism